Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort

Abstract Purpose Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI),...

Descripción completa

Detalles Bibliográficos

Autores principales:	Chunbo Li, Yan Ding, Xuyin Zhang, Keqin Hua
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Springer 2022-07-01
Colección:	Discover Oncology
Materias:	Gene mutation Immunotherapy Immune checkpoint LRP2 ICIs
Acceso en línea:	https://doi.org/10.1007/s12672-022-00528-8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!